Embolic protection: Limitations of current technology and novel concepts

International Journal of Cardiovascular Interventions

Volumn 7, Issue 4, 2005, Pages 176-182

  Hamood, Hatem ^a   Makhoul, Nabeel ^a   Hassan, Amin ^a   Shefer, Arie ^a   Rosenschein, Uri ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Emboli; Embolic protection device; No reflow; Percutaneous cardiovascular interventions; Stent

Indexed keywords

ADENOSINE; ADRENALIN; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; NITROPRUSSIDE SODIUM; POLITEF; VERAPAMIL;

ACUTE CORONARY SYNDROME; BALLOON OCCLUSION; CAROTID ARTERY; CAROTID ENDARTERECTOMY; CORONARY STENT; EMBOLISM; HEALTH CARE; HEART PROTECTION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; KIDNEY ARTERY; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; RENAL ARTERY; REVIEW; RISK REDUCTION; SAPHENOUS VEIN GRAFT; STANDARD; STENT;

EMBOLISM; HUMANS; RISK FACTORS; VASCULAR SURGICAL PROCEDURES;

EID: 29744443714     PISSN: 14628848     EISSN: 14711796     Source Type: Journal    
DOI: 10.1080/14628840500285038     Document Type: Review

References (70)

1. Baim DS, Wahr D, George B, et al., on behalf of the Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts. Circulation. 2002;105: r13-r18.
2. Stone GW, Rogers C, Hermiller J, et al., for the FilterWire EX Randomized Evaluation (FIRE) Investigator. Randomized Comparison of Distal Protection with a Filter-Based Catheter and a Balloon Occlusion and Aspiration System During Percutaneous Intervention of Diseased Saphenous Vein Aorto-Coronary Bypass Grafts. Circulation. 2003;108:548.
3. Brener SJ, Ellis SG, Schneider J, Topol EJ. Frequancy and long- term myonecrosis after coronary stenting. Eur Heart J. 2002;23:869-76.
4. Gruentzig AR. Seven years of coronary angioplasty. Z Kardiol. 1984;73(Suppl 2): 159-60.
5. Sanborn TA, Faxon DP, Waugh D, et al. Transluminal angioplasty in experimental atherosclerosis. Analysis for embolization using an in vivo perfusion system. Circulation. 1982;66:917-22.
6. Kotani J, Nanto S, Mintz GS, et al. Plaque Gruel of Atheromatous Coronary Lesion May Contribute to the No-Reflow Phenomenon in Patients With Acute Coronary Syndrome. Circulation. 2002;106:1672-7.
7. Kelly RV, et al. The no-reflow phenolmenon in coronary arteries. J Thromb Haemost. 2004;2:1903-7.
8. Trono R, et al. Multiple myocardial infarctions associated with atheromatous emboli after PTCA of saphenous vein grafts. Cleve Clin J Med. 1989;56:581-4.
9. Angelini A, Rubartelli P, Mistrorigo F, et al. Distal protection with a filter device during coronary stenting in patients with stable and unstable angina. Circulation. 2004;110:515-21.
10. Elliott JM, Berdan LG, Holmes DR, et al. One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). Circulation. 1995;91:2158-66.
11. Abdelmeguid AE, Topol EJ, Whitlow PL, et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous interventions. Circulation. 1996;94:1528-36.
12. Tardiff BE, Califf RM, Tcheng JE, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. J Am Coll Cardiol. 1999;33:88-96.
13. Saucedo JF, Mehran R, Dangas G, et al. Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol. 2000;35:1134-41.
14. Stone GW, Mehran R, Dangas G, et al. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation. 2001;104:642-7.
15. Stone GW. 2002 TCT meeting 7 BSC analysis using MEDPAR data.
16. Sangiorgi G., Colombo A. Embolic protection devices. Heart. 2003;89:990-2.
17. Antoniucci D et al. Direct infarct artery stenting without predilation and no- reflow in patients with acute myocardial infarction. Am Heart J. 2001;142:684-90.
18. Waller B, et al. Morphologic observations after percutaneous transluminal balloon angioplasty of early and late aortocoronary saphenous vein grafts. J Am Coll Cardiol. 1984;4:784-92.
19. Fuster V. Prevention of Atherosclerosis in Coronary-Artery Bypass Grafts. N Engl J Med. 1997;336:212-3.
20. Safian RD. Textor SC. Renal artery stenosis. N Engl J Med. 2001;344:431-42.
21. Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of "no-reflow" after percutaneous coronary intervention. Circulation. 1994;89:2514-8.
22. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105:1285-90.
23. Popma J, et al. Distal protection devices during percutaneous saphenous vein graft intervention: Has a new standard of acre been established? Current Interventional Cardiology Reports. 2001;3:275-8.
24. Roffi M, Mukherjee D, Chew DP, et al. Lack of benefit from intravenous platelet glycoprotein Ilb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts. Circulation. 2002;106:3063-7.
25. Ellis SG, Lincoff AM, Miller D, et al. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. J Am Coll Cardiol. 1998;32:1619-23.
26. Mathew V, Grill DE, Scott CG, et al. The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions. J Am Coll Cardiol. 1999;34:1163-9.
27. American heart association online: Stroke.
28. Roubin GS, New G, Iyer SS, et al. Immediate and Late Clinical Outcomes of Carotid Artery Stenting in Patients with Symptomatic and Asymptomatic Carotid Artery Stenosis-A 5-Year Prospective Analysis. Circulation. 2001;103:532-7.
29. Yadav JS, Roubin GS, King P, et al. Angioplasty and stenting for restenosis after carotid endarterectomy: initial experience. Stroke. 1996;27:2075-1079.
30. American heart association on-line. Carotid endarterectomy. 31. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-87.
31. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421-8.
32. Barnett HJM, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998;339:1415-25.
33. Roubin GS, New G, Iyer SS, et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation. 2001;103:532-7.
34. Zahn R, Mark B, Niedermaier N, et al., for the (ALKK) Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte. Embolic protection devices for carotid artery stenting: better results than stenting without protection? Eur Heart J. 2004;25:1550-8.
35. Roubin GS, Iyer SS, Vitek JJ, et al., editors. Peripheral vascular stenting for cardiologists. first ed. Carotid artery stenting: rationale, indications, technique and results. London: Martin Dunitz Ltd, 1999. pp. 67-118.
36. CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001;357:1729-37.
37. Ohki T, Veith FJ. Carotid artery stenting: utility of cerebral protection devices. J Invasive Cardiol. 2001;13:47-55.
38. Theron J, Courtheoux P, Alachkar F, et al. New triple coaxial catheter system for carotid angioplasty with cerebral protection. Am J Neuroradiol. 1990;11:869-74.
39. Kastrup A, Groschel K, Krapf H, et al. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke. 2003;34:813-9.
40. Al Mubarak N, Roubin GS, Vitek JJ, et al. Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation. 2001;104:1999.
41. Wholey MH, Jarmolowski CR, Wholey M, et al. Carotid artery stent placement-ready for prime time. J Vasc Interv Radiol. 2003;14:1-10.
42. Wholey MH, Al Mubarek N, Wholey MH. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv. 2003;60:259-66.
43. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotidartery stenting versus endarterectomy in high-risk patients: SAPPHIRE trial. N Engl J Med. 2004;351:1493-501.
44. White CJ. Another nail in the coffin of carotid endarterectomy. J Am Coll Cardiol. 2001;38:1596-7.
45. TCTMD.com, J. Hakim, MD, report from TCT 2002.
46. American heart association online: Acute myocardial infarction.
47. Andersen HR et al. A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarcion. N Engl J Med. 2003;349:733-42.
48. Widimsky P, Budesinsky T, Vorac D, et al., 'PRAGUE' Study Group Investigators. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2. Eur Heart J. 2003;24:94-104.
49. Grines CL, Westerhausen DR, Grines LL, et al. A randomized trial of transfer for primary angioplasty vs on-site thrombolysis in patients with high-risk myocardial infarction: the air primary angioplasty in myocardial infarction study. J Am Coll Cardiol. 2002;39:1713-9.
50. Vermeer F, Oude Ophuisa AJM, Bergb EJ, et al. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart. 1999;82:426-31.
51. Stone et al. Distal microcircularity protection during PCI in Acute RST - segment Elevation Myocardial Infarction: EMERALD - a randomized control study. JAMA. 2005;293:1063-72.
52. Gick M, Jander N, Bestehorn HP, et al. A randomized study on the effectiveness of filter device for distal protection during direct percutaneous catheter intervention for acute myocardial infarction: results of the PROMISE (Protection devices in PCI-Treatment of MI for Salvage of Endangered Myocardium) Study. Presented at: Late Breaking Clinical Trials: 54th Annual Scientific Session of the American College of Cardiology; 6-9 March 2005; Orlando, FL
53. Sacco RL. Extracranial Carotid Stenosis. N Engl J Med. 2001;15:1113-8.
54. Yamashita T, Ito F, Iwakiri N, et al. Prevalence and predictors of renal artery stenosis in patients undergoing cardiac catheterization. Hypertens Res. 2002;25:553-7.
55. Dorros G, Jaff M, Mathiak L, et al. Four-Year Follow-up of Palmaz-Schatz Stent Revascularization as Treatment for Atherosclerotic Renal Artery Stenosis. Circulation. 1998;98:642-7.
56. Watson PS, Hadjipetrou P, Stephen V, et al. Effect of Renal Artery Stenting on Renal Function and Size in Patients with Atherosclerotic Renovascular Disease. Circulation. 2000;102:1671-7.
57. Dean RH, et al. Evolution of renal insufficiency in ischemic nephropathy. Ann Surg. 1991;213:446-55.
58. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med. 1993;118:712-9.
59. van Jaarsveld BC, Krijnen P, Pieterman H, et al., for The Dutch Renal Artery Stenosis Intervention Cooperative Study Group. The Effect of Balloon Angioplasty on Hypertension in Atherosclerotic Renal-Artery Stenosis. N Engl J Med. 2000;342:1007-14.
60. Jensen G, Zachrisson B-F, Denlin K, et al. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int. 1995;48:1936-45.
61. Rundback JH, Jacobs JM. Percutaneous renal artery stent placement for hypertension and azotemia: pilot study. Am J Kidney Dis. 1996;28:214-9.
62. Losino F, Zuccala A, Busato F, et al. Renal artery angioplasty for renovascular hypertension and preservation of renal function: long-term angiographic and clinical follow-up. AJR. 1994;162:853-7.
63. Sabeti S, Schillinger M, Mlekusch W, Ahmadi R, Minar E. Reduction in renal function after renal arteriography and after renal artery angioplasty. Eur J Vasc Endovasc Surg. 2002;24:156-60.
64. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000;101:570-80.
65. The Wall Street Journal 19 October 2000.
66. MedPro Month November-December 2000, 315.
67. Embolic Protection Systems: www.medtronic.com.
68. Debabrata Mukherjee. Role of emboli protection devices in native and saphenous vein graft percutaneous interventions. ACC Current Journal Review. 2004;Sept:32-35.
69. Rogers C, Huynh R, Philip A, et al. Embolic Protection with Filtering or Occlusion Balloons During Saphenous Vein Graft Stenting Retrieves Identical Volumes and Sizes of Particulate Debris. Circulation. 2004;109:1735-40.
70. Eberhard Grube, Ulrich Gerckens, Alan C, et al. Prevention of Distal Embolization During Coronary Angioplasty in Saphenous Vein Grafts and Native Vessels Using Porous Filter Protection. Circulation. 2001;104:2436-41.